MT Weekly: Australia Fights BIA-ALCL, Ireland Refuses Recourse to Mesh-Injured

James Parker · October 21, 2019

Last week in medical brought about delay in an opioid trial against Purdue Pharmaceuticals and the Sackler family while the two determine how much of the settlement the Sacklers should pay. Meanwhile, actions were made against BIA-ALCL in Australia and Ireland, where warnings were sent to the public. Ireland's mesh-injured population is denied financial compensation for their harm.

News

MT Weekly: J&J Mistrial Declared, 'No JUULS' Requested for Schools

James Parker · September 16, 2019

In this week's MT Weekly, Purdue Pharma and the Sacklers negotiated settlements, while pharmaceutical manufacturer Mallinckrodt agreed to a $30 million settlement. Trials on talc and Roundup brought stalemates. Still, global HIV efforts and criticisms of JUUL e-cigarettes bring hope for public health.

Health Features

Opioid Link Has Sackler Family Donations Declined By Museums

S. Nicole Lane · May 23, 2019

The Sackler family has profited for years from their personal connections to Purdue Pharma amid the opioid crisis. Now, esteemed museums like the Met, Tate Modern, and the Guggenheim decline the Sackler Family Donations following public backlash.

Legal Developments

MT Weekly: Foodborne Illness Outbreaks, Sackler Steers Opioids to China

Carah Wertheimer · November 25, 2019

While the U.S. observes urgent calls for bans on vaping products, the Sackler family catapults the opioid crisis abroad, with their affiliate company Mundipharma promoting OxyContin in China. Additionally, last week brought about several foodborne illness outbreaks, new findings on the rising prevalence of anal cancer, and a promising HIV vaccine discovery.

News